Journal
BLOOD
Volume 118, Issue 26, Pages 6849-6859Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-02-338434
Keywords
-
Categories
Funding
- Northwestern University Mouse Histology and Phenotyping Laboratory
- National Cancer Institute [CA060553, CA 133063, CA73507, 5P01CA092372]
- Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility
- Carcinogenesis Training Program [T32CA009560]
Ask authors/readers for more resources
The link between EBV infection and Burkitt lymphoma (BL) is strong, but the mechanism underlying that link has been elusive. We have developed a mouse model for EBV-associated BL in which LMP2A, an EBV latency protein, and MYC are expressed in B cells. Our model has demonstrated the ability of LMP2A to accelerate tumor onset, increase spleen size, and bypass p53 inactivation. Here we describe the results of total gene expression analysis of tumor and pretumor B cells from our transgenic mouse model. Although we see many phenotypic differences and changes in gene expression in pretumor B cells, the transcriptional profiles of tumor cells from LMP2A/lambda-MYC and lambda-MYC mice are strikingly similar, with fewer than 20 genes differentially expressed. We evaluated the functional significance of one of the most interesting differentially expressed genes, Egr1, and found that it was not required for acceleration of tumor onset by LMP2A. Our studies demonstrate the remarkable ability of LMP2A to affect the pretumor B-cell phenotype and tumorigenesis without substantially altering gene expression in tumor cells. (Blood.2011;118(26):6849-6859)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available